The reason TRST Goes Up FAts And down Slower a fraction of the outstanding shares vs ACB, WEED and APHA... a safer play and a more alive investor shareholders who drove the stock up 32% in 1 day when they announced : Canntrust earns $421,240 in Q3 2018 30+% Increase the next day...
Mr. Peter Aceto reports
CANNTRUST REPORTS RECORD REVENUE FOR Q3 2018 AND IS TAKING STEPS TO LIST ON THE NEW YORK STOCK EXCHANGE
Canntrust Holdings Inc. has released its financial and operating results for the three and nine months ended Sept. 30, 2018.
Revenue for the three-month and nine-month periods ended Sept. 30, 2018, was $12,588,727 and $29,478,813, respectively, compared with $6,140,224 and $13,714,847 in the comparable 2017 periods. Net income for the three-month and nine-month periods ended Sept. 30, 2018, was $421,240 and $11,968,255, respectively, compared with a net income of $655,309 and $632,269 in the comparable 2017 periods. Earnings per share for the three-month and nine-month periods ended Sept. 30, 2018, were nil and 12 cents, respectively, compared with earnings per share of one cent and one cent in the comparable 2017 periods.
2018 third quarter highlights:
Developments subsequent to the quarter:
| 2018-11-15 | T | TRST | 7.53 | 9.455 | 7.52 | 9.40 | 2.18 |
| 2018-11-14 | T | TRST | 7.69 | 7.75 | 7.00 | 7.22 | -0.61 |
2018-11-14 16:26 ET - News Release
CANNTRUST REPORTS RECORD REVENUE FOR Q3 2018 AND IS TAKING STEPS TO LIST ON THE NEW YORK STOCK EXCHANGE
Canntrust Holdings Inc. has released its financial and operating results for the three and nine months ended Sept. 30, 2018.
Revenue for the three-month and nine-month periods ended Sept. 30, 2018, was $12,588,727 and $29,478,813, respectively, compared with $6,140,224 and $13,714,847 in the comparable 2017 periods. Net income for the three-month and nine-month periods ended Sept. 30, 2018, was $421,240 and $11,968,255, respectively, compared with a net income of $655,309 and $632,269 in the comparable 2017 periods. Earnings per share for the three-month and nine-month periods ended Sept. 30, 2018, were nil and 12 cents, respectively, compared with earnings per share of one cent and one cent in the comparable 2017 periods.
2018 third quarter highlights:
- Record revenues of $12.6-million in Q3 2018, a 105-per-cent increase from the comparable prior-year period;
- Operations for the quarter resulted in positive EBITDA (earnings before interest, taxes, depreciation and amortization) and positive net income;
- Active patients increased to more than 50,000, a 61-per-cent increase from the comparable prior-year period;
- Entered into supply agreements with nine Canadian provinces to supply recreational cannabis across Canada;
- Launched a fourth recreational brand -- Peak Leaf;
- Made the company's first shipment of cannabis oil to Denmark -- the only cannabis oil accepted in Denmark;
- Partnered with Australia's Gold Coast University Hospital on a six-month study designed to evaluate the efficacy of Canntrust cannabidiol (CBD) capsules in slowing the progression of amyotrophic lateral sclerosis (ALS) progression;
- Partnered with McMaster University on medicinal cannabis research for chronic pain and for designing more effective, safer treatment protocols in public health policies.
Developments subsequent to the quarter:
- Invested in National Access Cannabis Corp. (NAC), a Canadian cannabis retailer;
- Entered into an exclusive partnership agreement with Kindred Partners Inc., a wholly owned Canadian subsidiary of Breakthru Beverage Group, the largest Canadian beverage alcohol broker, to provide sales support for recreational products and to subscribe for 902,405 common shares for gross proceeds of $9.2-million;
- Expanded the company's global reach by entering into a strategic partnership with Australian licensed producer, Cannatrek Ltd., with plans in place for construction of a 1.7-million-square-foot greenhouse facility;
- Acquired a 19.4-acre property adjacent to the company's Niagara greenhouse facility, which allows the company to expand production capacity;
- Strengthened the company's management team and board of directors.
| Fundamental Data - TRST |
| Security Type | Equity |
| Shares Issued | 105,109,653 |
| Market Cap | 893,432,000 |
| Year High | 15.50 |
| Year Low | 5.86 |
| House Positions for C:TRST from 20181126 to 20181126 |
| House | Bought | $Val | Ave | Sold | $Val | Ave | Net | $Net |
|---|---|---|---|---|---|---|---|---|
| 7 TD Sec | 645,452 | 5,394,341 | 8.357 | 184,746 | 1,570,038 | 8.498 | 460,706 | -3,824,303 |
| 1 Anonymous | 779,658 | 6,541,389 | 8.39 | 515,651 | 4,338,804 | 8.414 | 264,007 | -2,202,585 |
| 14 ITG | 74,076 | 625,205 | 8.44 | 4,000 | 34,534 | 8.634 | 70,076 | -590,671 |
| 89 Raymond James | 80,946 | 689,034 | 8.512 | 45,628 | 379,189 | 8.31 | 35,318 | -309,845 |
| 13 Instinet | 94,700 | 799,818 | 8.446 | 69,826 | 585,340 | 8.383 | 24,874 | -214,478 |
| 124 Questrade | 47,193 | 409,177 | 8.67 | 27,410 | 233,338 | 8.513 | 19,783 | -175,839 |
| 143 Pershing | 15,523 | 127,817 | 8.234 | 1,030 | 8,578 | 8.328 | 14,493 | -119,239 |
| 22 Fidelity | 44,452 | 379,919 | 8.547 | 37,302 | 311,239 | 8.344 | 7,150 | -68,680 |
| 99 Jitney | 41,400 | 345,002 | 8.333 | 34,900 | 289,413 | 8.293 | 6,500 | -55,589 |
| 19 Desjardins | 10,365 | 88,330 | 8.522 | 7,180 | 61,900 | 8.621 | 3,185 | -26,430 |
| 59 PI | 1,565 | 13,419 | 8.574 | 0 | 1,565 | -13,419 | ||
| 36 Latimer | 571 | 4,786 | 8.382 | 448 | 3,846 | 8.585 | 123 | -940 |
| 18 Echelon | 25,000 | 216,650 | 8.666 | 25,000 | 216,650 | 8.666 | 0 | 0 |
| 6 Infor | 3,600 | 29,407 | 8.169 | 3,600 | 30,137 | 8.371 | 0 | 730 |
| 57 Interactive | 798 | 6,813 | 8.538 | 989 | 8,252 | 8.344 | -191 | 1,439 |
| 2 RBC | 77,429 | 649,431 | 8.387 | 77,686 | 649,317 | 8.358 | -257 | -114 |
| 70 Manulife | 0 | 1,000 | 8,580 | 8.58 | -1,000 | 8,580 | ||
| 74 GMP | 1,950 | 15,755 | 8.079 | 3,000 | 25,775 | 8.592 | -1,050 | 10,020 |
| 15 UBS | 0 | 1,319 | 11,330 | 8.59 | -1,319 | 11,330 | ||
| 28 BBS | 120 | 978 | 8.15 | 2,100 | 17,648 | 8.404 | -1,980 | 16,670 |
| 88 Credential | 4,735 | 39,839 | 8.414 | 7,706 | 65,863 | 8.547 | -2,971 | 26,024 |
| 9 BMO Nesbitt | 77,758 | 642,734 | 8.266 | 81,800 | 670,848 | 8.201 | -4,042 | 28,114 |
| 53 Morgan Stanley | 27,254 | 227,828 | 8.359 | 38,956 | 324,106 | 8.32 | -11,702 | 96,278 |
| 33 Canaccord | 0 | 12,306 | 104,106 | 8.46 | -12,306 | 104,106 | ||
| 80 National Bank | 36,758 | 309,616 | 8.423 | 54,183 | 450,204 | 8.309 | -17,425 | 140,588 |
| 79 CIBC | 389,300 | 3,257,053 | 8.366 | 482,399 | 4,056,899 | 8.41 | -93,099 | 799,846 |
| 85 Scotia | 82,006 | 692,179 | 8.441 | 224,818 | 1,896,657 | 8.436 | -142,812 | 1,204,478 |
| 39 Merrill Lynch | 91,567 | 764,223 | 8.346 | 298,081 | 2,510,233 | 8.421 | -206,514 | 1,746,010 |
| 65 Goldman | 55,060 | 461,252 | 8.377 | 466,172 | 3,869,171 | 8.30 | -411,112 | 3,407,919 |
| TOTAL | 2,709,236 | 22,731,995 | 8.391 | 2,709,236 | 22,731,995 | 8.391 | 0 | 0 |